Re-live UEG Week

UEG Week edition 2025

UEG Week 2026 UEG Week 2025 UEG Week 2024 UEG Week 2023

until 09:30 · Room 6.2B PGT 5 on Gutflix

Metabolic and vascular disorders of the liver

until 09:30 · Room A1 PGT 5 on Gutflix

Is the surgical "era" coming to an end?

until 09:30 · Room A3 PGT 5 on Gutflix

A 360-degree appraisal of acute pancreatitis

until 09:30 · Room A6 PGT 5 on Gutflix

Untangling malabsorption in dysmotility and short bowel syndrome

until 09:30 · Room Helsinki PGT 6 on Gutflix

Best of Barrett’s oesophagus

more in parallel Show fewer

until 09:30 · Room 6.2B 3 on Gutflix

The art of making clinical research precise: Predicting therapy response in IBD

until 09:30 · Room A1 5 on Gutflix

Monitoring IBD by imaging

until 09:30 · Room A2 3 on Gutflix

Spastic oesophagus: Is it curable?

until 09:30 · Room A3 4 on Gutflix

Molecular medicine: Understanding the mechanism allows therapy

until 09:30 · Room A4 5 on Gutflix

Lower GI motility I

until 09:30 · Room A5 5 on Gutflix

EoE: From gene to clinic

until 09:30 · Room A6 3 on Gutflix

Game changers in lower GI over the past decade: Neoplasm

until 09:30 · Room A7 3 on Gutflix

From guidelines to clinical practice: The gut-brain connection - PPIs and guideline application in clinical practice

until 09:30 · Room A8 3 on Gutflix

Crash course: Tough endoscopists for tough stones

until 09:30 · Room Budapest 5 on Gutflix

Oncobiome

until 09:30 · Room Dublin 3 on Gutflix

Quality of upper endoscopy: Is AI the answer?

until 09:30 · Room Helsinki 3 on Gutflix

Challenges in metabolic liver diseases

more in parallel Show fewer

until 09:30 · Room 6.2B 3 on Gutflix

Therapy update: MASH and metabolic disorders

until 09:30 · Room A1 5 on Gutflix

Dissecting the microbiome in gut inflammation

until 09:30 · Room A2 3 on Gutflix

The art of making clinical research precise: Can we unlock the microbiome?

until 09:30 · Room A3 3 on Gutflix

Diet and disorders of gut-brain interaction: From IBS to IBD

until 09:30 · Room A4 5 on Gutflix

Lower GI: Surgical considerations

until 09:30 · Room A5 5 on Gutflix

Coeliac disease: From screening to new drugs

until 09:30 · Room A6 3 on Gutflix

Obesity in Pan America

until 09:30 · Room A7 5 on Gutflix

Mistakes in…: Upper GI

until 09:30 · Room A8 3 on Gutflix

Pancreatic cancer

until 09:30 · Room Budapest 4 on Gutflix

Detecting polyps with the help of AI

until 09:30 · Room Dublin 1 on Gutflix

ESGE Live Endoscopy I

until 09:30 · Room Helsinki 3 on Gutflix

Barrett's oesophagus: Are we getting there?

more in parallel Show fewer

until 10:30 · Room 6.2B PGT 6 on Gutflix

When the alarm bells go off: Approach to acute severe colitis

until 10:30 · Room A5 5 on Gutflix

ESGENA: Opening Session

until 11:30 · Room 6.2B PGT 7 on Gutflix

Is there really an added value for all new EUS/ERCP techniques?

until 11:30 · Room A1 PGT 5 on Gutflix

Acute and chronic mesenteric ischaemia

until 11:30 · Room A3 PGT 8 on Gutflix

Immunotherapy in digestive cancers: Where are we heading?

until 11:30 · Room A4 6 on Gutflix

Abstracts II: Patient care and endoscopic techniques

until 11:30 · Room A5 4 on Gutflix

Patient care: Differences matter

until 11:30 · Room A6 PGT 6 on Gutflix

Liver and pregnancy: Beware of dangerous liaisons

until 11:00 · Room A7 1 on Gutflix

From Adiposity to Hepatic Health: Exploring the Pleiotropic Clinical Impact of Semaglutide (Novo Nordisk)

until 11:00 · Room Dublin 1 on Gutflix

Charting the course in IBD: Achieving early and sustained control with IL-23 inhibitors (AbbVie)

until 11:30 · Room Helsinki PGT 6 on Gutflix

Non-cardiac chest pain: The tale of a sore oesophagus

more in parallel Show fewer

until 11:00 · Room 6.2B 3 on Gutflix

Large controversies for large polyps

until 11:00 · Room A1 5 on Gutflix

Targeting gastric cancer: How to proceed

until 11:00 · Room A2 3 on Gutflix

Coeliac or non-coeliac enteropathy?

until 11:00 · Room A3 3 on Gutflix

The art of making clinical research precise: Clinical research in context

until 11:00 · Room A4 5 on Gutflix

From The Lion King to Waterland: A journey through pancreatitis

until 11:00 · Room A5 5 on Gutflix

Endoscopic resection in the upper GI tract

until 11:00 · Room A6 3 on Gutflix

Catching up with every day's practise in colorectal cancer treatment

until 11:00 · Room A7 3 on Gutflix

FMT: What’s new?

until 11:00 · Room A8 3 on Gutflix

New developments in liver transplantation

until 11:00 · Room Budapest 5 on Gutflix

IBD: What about the environment?

until 11:00 · Room Dublin 3 on Gutflix

What’s new in AI and big data in HPB in 2025?

until 11:00 · Room Helsinki 5 on Gutflix

Hot off the press: IBD treatment

more in parallel Show fewer

until 11:00 · Room 6.2B 3 on Gutflix

How to optimise success in IBD treatment

until 11:00 · Room A1 5 on Gutflix

Predicting clinical outcomes in IBD

until 11:00 · Room A2 3 on Gutflix

Developments in autoimmune HPB disease

until 11:00 · Room A3 2 on Gutflix

Disease primer: Microbiome in diagnosis and treatment of GI disorders

until 11:00 · Room A4 4 on Gutflix

Cogulation, lipids and bugs: All relevant for pancreatitis

until 11:00 · Room A5 5 on Gutflix

Complexity and diversity in upper GI

until 11:00 · Room A6 3 on Gutflix

Bloating

until 11:00 · Room A7 3 on Gutflix

Hot topics from Pan America: Hepatitis B in Latin America - Situation and management by 2025

until 11:00 · Room A8 3 on Gutflix

Cystic neoplasms of the pancreas

until 11:00 · Room Budapest 5 on Gutflix

Lifestyle management and therapy in MASLD

until 11:00 · Room Dublin 1 on Gutflix

ESGE Live Endoscopy II

until 11:00 · Room Helsinki 2 on Gutflix

Disease primer: From H.pylori to gastric cancer

more in parallel Show fewer

until 12:30 · Room 6.2B PGT 4 on Gutflix

The Crohn´s disease journey

until 12:30 · Room A1 PGT 5 on Gutflix

From risk to recovery: A postgraduate dive into gastric cancer care

until 12:30 · Room A3 PGT 6 on Gutflix

Cholangiocarcinoma secrets unveiled

until 12:30 · Room A4 5 on Gutflix

New trends and developments in hygiene and infection control

until 12:30 · Room A5 6 on Gutflix

New trends and developments in endoscopic techniques

until 12:30 · Room A6 PGT 5 on Gutflix

Hereditary GI cancer syndromes: Surveillance strategies

until 12:30 · Room Helsinki PGT 5 on Gutflix

Colorectal and duodenal polypectomy: Characterisation, choice of technique and pushing the boundaries

more in parallel Show fewer

until 12:30 · Room 6.2B 3 on Gutflix

What's new in ulcerative colitis 2025?

until 12:30 · Room A1 5 on Gutflix

Lower GI: Before resection comes a good characterisation

until 12:30 · Room A2 3 on Gutflix

When adult gastroenterologist meets paediatrician: Focus on reflux, constipation and chronic pain

until 12:30 · Room A3 3 on Gutflix

The art of making clinical research precise: Options for study design

until 12:30 · Room A4 5 on Gutflix

Molecular medicine: From mechanism to diagnosis

until 12:30 · Room A5 5 on Gutflix

Artificial intelligence in IBD

until 12:30 · Room A6 3 on Gutflix

The small and serrated polyp

until 12:30 · Room A7 5 on Gutflix

Mistakes in …: Hepatobiliary and pancreas

until 12:30 · Room A8 3 on Gutflix

Advancement in management of primary liver tumors

until 12:30 · Room Budapest 5 on Gutflix

Lower GI motility II

until 12:30 · Room Dublin 4 on Gutflix

Therapy update: Acute severe pancreatitis – It's all about timing!

until 12:30 · Room Helsinki 2 on Gutflix

Is your GI-practice sustainable?

more in parallel Show fewer

until 12:30 · Room 6.2B 3 on Gutflix

When IBD and IBS experts collaborate for optimal diagnosis and treatment of IBD with IBS-like symptoms

until 12:30 · Room A1 3 on Gutflix

MASLD: Inflammatory mechanisms

until 12:30 · Room A2 3 on Gutflix

Infectious and rare hepatitis

until 12:30 · Room A3 5 on Gutflix

Predicting and understanding early stages of advanced liver disease

until 12:30 · Room A4 5 on Gutflix

PDAC surveillance and treatment: The how's and why's

until 12:30 · Room A5 5 on Gutflix

The gut ecosystem: From pathogenesis to treatment

until 12:30 · Room A6 4 on Gutflix

Therapy update: EoE

until 12:30 · Room A7 3 on Gutflix

The art of making clinical research precise: Biomarkers of the future - Is it liquid gold?

until 12:30 · Room A8 3 on Gutflix

Acute pancreatitis

until 12:30 · Room Budapest 4 on Gutflix

New tales of the gut microbiome: From profiling to new therapies

until 12:30 · Room Dublin 1 on Gutflix

ESGE Live Endoscopy III

until 12:30 · Room Helsinki 3 on Gutflix

What's new in early oesophageal cancer in 2025?

more in parallel Show fewer

until 13:00 · Room A1 1 on Gutflix

Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care (Sanofi Regeneron)

until 13:00 · Room A4 3 on Gutflix

Hygiene: Update 2025

until 13:00 · Room A5 3 on Gutflix

Staff safety and management  

until 13:00 · Room A6 1 on Gutflix

Navigating the IL-23 universe: breaking frontiers in ulcerative colitis (Johnson and Johnson)

until 13:00 · Room Dublin 1 on Gutflix

JAK inhibitors in IBD: Overtaking inflammation from the start (AbbVie)

until 13:00 · Room Helsinki 1 on Gutflix

Driving the evolution of treatment goals in UC management: Long-term remission with mirikizumab (Eli Lilly and Company)

more in parallel Show fewer

until 14:00 · Room A1 1 on Gutflix

Rethinking IBD Treatment: Novel Mechanisms and the Future of IBD Therapy (Sanofi) 

until 14:00 · Room A2 1 on Gutflix

EUS-guided biliary drainage

until 14:00 · Room A5 1 on Gutflix

The pregnant IBD patient

until 14:00 · Room A6 1 on Gutflix

Navigating the IL-23 universe: breaking frontiers in Crohn’s disease (Johnson and Johnson)

until 14:00 · Room A7 1 on Gutflix

A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Catalyst Medical Education, LLC)

until 14:00 · Room Dublin 1 on Gutflix

Paving the way to comprehensive management in CD: Long-term remission with mirikizumab (Eli Lilly and Company)

until 14:00 · Room Helsinki 1 on Gutflix

Early onset life-long impact: Caustic injury/atresia

more in parallel Show fewer

until 14:00 · Room A1 1 on Gutflix

Optimal Approaches to Initial Management of Ulcerative Colitis and Clostridioides difficile Infection (Tillotts Pharma AG)

until 14:00 · Room A2 1 on Gutflix

Chronic constipation

until 14:00 · Room A5 1 on Gutflix

Early versus delayed endoscopic necrosectomy

until 14:00 · Room Helsinki 1 on Gutflix

Early gastric cancer

more in parallel Show fewer

until 15:00 · Room 6.2B PGT 4 on Gutflix

Houston we have a problem! GI bleeding and endoscopic therapy of endoscopic and surgical complications

until 15:00 · Room A1 PGT 5 on Gutflix

The rocky road: Treatment standards for biliary stones

until 15:00 · Room A3 PGT 6 on Gutflix

Diabetes in GI disorders

until 15:00 · Room A4 5 on Gutflix

Innovative approaches in liver disease management

until 15:00 · Room A5 6 on Gutflix

Abstracts I: Management and education

until 15:00 · Room A6 PGT 5 on Gutflix

Autoimmune disease of liver and bile ducts

until 15:00 · Room Helsinki PGT 6 on Gutflix

Cystic pancreatic lesions

more in parallel Show fewer

until 15:00 · Room 6.2B 9 on Gutflix

Opening Plenary

until 15:00 · Room A4 4 on Gutflix

Endoscopic techniques: Emergency and difficult situations  

until 15:00 · Room A5 4 on Gutflix

Education: Important tool for quality in endoscopy

until 15:30 · Room 6.2B 3 on Gutflix

Focus on fistulising Crohn’s disease 

until 15:30 · Room A1 5 on Gutflix

Colorectal ESD: The better way?

until 15:30 · Room A2 3 on Gutflix

Cross-cutting: Management changes in high prevalence problems

until 15:30 · Room A3 3 on Gutflix

The art of making clinical research precise: Narrowing the gap between the bench and bedside

until 15:30 · Room A4 5 on Gutflix

Randomised controlled trials in upper GI endoscopy

until 15:30 · Room A5 3 on Gutflix

Predicting response to IBD therapy

until 15:30 · Room A6 3 on Gutflix

Crash course: Lower GI bleeding

until 15:30 · Room A7 3 on Gutflix

From guidelines to clinical practice: Bringing guidelines to life - Tackling malabsorption in clinical practice

until 15:30 · Room A8 3 on Gutflix

Microbiome at the cross-roads of GI cancer

until 15:30 · Room Budapest 5 on Gutflix

Lower GI motility III

until 15:30 · Room Dublin 3 on Gutflix

Chronic pancreatitis and rare etiologies

until 15:30 · Room Helsinki 4 on Gutflix

Unexpected novel therapies tackling intestinal inflammation

more in parallel Show fewer

until 15:30 · Room 6.2B 3 on Gutflix

Endoscopy, cancer and IBD

until 15:30 · Room A1 5 on Gutflix

Latest news: From top to bottom

until 15:30 · Room A2 3 on Gutflix

Disorders of gut‐brain interaction: Dietary restrictions 

until 15:30 · Room A3 4 on Gutflix

Early colorectal cancer

until 15:30 · Room A4 5 on Gutflix

Endoscopic solutions to malignant biliary obstruction

until 15:30 · Room A5 5 on Gutflix

Tackling IBD in clinics

until 15:30 · Room A6 3 on Gutflix

ACLF and cirrhosis: Are we improving care?

until 15:30 · Room A7 3 on Gutflix

Breath testing and clinical metabolomics: Back to the future

until 15:30 · Room A8 3 on Gutflix

Therapy update: Dyspepsia

until 15:30 · Room Budapest 5 on Gutflix

From prediction to detection in upper GI

until 15:30 · Room Dublin 3 on Gutflix

Non-variceal bleeding: Planning an emergency

until 15:30 · Room Helsinki 5 on Gutflix

Advanced therapies in ulcerative colitis

more in parallel Show fewer

until 17:00 · Room 6.2B PGT 6 on Gutflix

Cancer and IBD: Mitigating risk among uncertainty

until 17:00 · Room A1 PGT 7 on Gutflix

Into the depths! Guiding minimally-invasive management of small-bowel pathology

until 17:00 · Room A3 PGT 6 on Gutflix

The ultimate guide to colorectal cancer staging surgery adjuvant treatment

until 17:00 · Room A4 4 on Gutflix

IBD nurses: All around the gut

until 17:00 · Room A5 4 on Gutflix

Green endoscopy: What makes sense?

until 17:00 · Room A6 PGT 6 on Gutflix

Hepatocellular carcinoma: All you need to know

until 17:00 · Room Helsinki PGT 7 on Gutflix

Easily overlooked cases of chronic diarrhoea

more in parallel Show fewer

until 16:30 · Room 6.2B 3 on Gutflix

What's new in advanced therapies for IBD in 2025?

until 16:30 · Room A1 5 on Gutflix

Improving decision-making in colorectal lesions

until 16:30 · Room A2 3 on Gutflix

Managing reflux at multiple levels

until 16:30 · Room A3 3 on Gutflix

Predicting patient outcomes...

until 16:30 · Room A4 5 on Gutflix

Textbook knowledge and limits of HPB endoscopy

until 16:30 · Room A5 5 on Gutflix

H. pylori: Between bench and bedside

until 16:30 · Room A6 3 on Gutflix

What's new in complications in chronic liver disease in 2025?

until 16:30 · Room A7 3 on Gutflix

Predicting disease severity

until 16:30 · Room A8 3 on Gutflix

Gastric cancer: MDT approach

until 16:30 · Room Budapest 4 on Gutflix

Advances in management of immune-mediated biliary disease

until 16:30 · Room Dublin 3 on Gutflix

From guidelines to clinical practice: Pancreatic lesions, PCN and acute pancreatitis

until 16:30 · Room Helsinki 5 on Gutflix

Clinical management of IBD

more in parallel Show fewer

until 17:00 · Room 6.2B 3 on Gutflix

Never waste a good disaster

until 17:00 · Room A1 5 on Gutflix

Treatment of fistulas in Crohn's disease

until 17:00 · Room A2 3 on Gutflix

Crash course: Foreign bodies

until 17:00 · Room A3 3 on Gutflix

The art of making clinical research precise: What will be new in therapy in 2030?

until 17:00 · Room A4 5 on Gutflix

It's all about the right technique: Colorectal lesions

until 17:00 · Room A5 4 on Gutflix

Burning issues in GERD

until 17:00 · Room A6 4 on Gutflix

Screening for colorectal cancer: Can we stratify the risks?

until 17:00 · Room A7 3 on Gutflix

Rising Stars from Europe and Japan: Metabolic liver diseases

until 17:00 · Room A8 3 on Gutflix

Cross-cutting: Primary sclerosing cholangitis and IBD

until 17:00 · Room Budapest 5 on Gutflix

Prediction and prognosis of pre-malignant and malignant pancreatic lesions

until 17:00 · Room Dublin 4 on Gutflix

Post-OP complications: When do we need to step in?

until 17:00 · Room Helsinki 3 on Gutflix

Disease primer: From inflammation to restoration - wound healing in IBD

more in parallel Show fewer

until 18:00 · Room 6.2B 3 on Gutflix

IBD across all ages

until 18:00 · Room A1 3 on Gutflix

The art of making clinical research precise: AI – friend or foe?

until 18:00 · Room A2 6 on Gutflix

Hot topics in European gastroenterology

until 18:00 · Room A3 5 on Gutflix

Bench to bedside and beyond frontiers in HCC

until 18:00 · Room A4 3 on Gutflix

New insights into IBD pathology

until 18:00 · Room A5 7 on Gutflix

Video Case Session: Third space endoscopy

until 18:00 · Room A6 5 on Gutflix

Mistakes in…: Lower GI

until 18:00 · Room A7 2 on Gutflix

Predicting therapy response 

until 18:00 · Room A8 3 on Gutflix

What's new in coeliac disease in 2025?

until 18:00 · Room Budapest 5 on Gutflix

Advances in the investigation of the small bowel

until 18:00 · Room Dublin 4 on Gutflix

Best of DDW

until 18:00 · Room Helsinki 5 on Gutflix

Late-breaking trials in IBD

more in parallel Show fewer

until 18:30 · Room A1 1 on Gutflix

Benefits of a combination of xyloglucan and pea protein in functional intestinal disorders (Reckitt)

until 18:30 · Room A1 1 on Gutflix

When & for Whom: Intravenous vs Subcutaneous Therapies in IBD Maintenance (Celltrion)

until 18:30 · Room A2 1 on Gutflix

Innovations in IBD Therapy: The Story of TL1A -  from Discovery to Potential Future Care (F. Hoffmann-La Roche Ltd)

until 18:30 · Room A5 1 on Gutflix

Redefining EoE Treatment Success through Real-World Cases (Sanofi Regeneron)

until 18:30 · Room A7 1 on Gutflix

Advances in PBC Management: A Simple Approach (Gilead)

until 18:30 · Room Helsinki 1 on Gutflix

From Evolution to Revolution: New Mechanisms of Action in Ulcerative Colitis (Abivax)

more in parallel Show fewer